$852.35
-12.55-1.45%
At close: -
$853.00
0.650.08%
After Hours: 7:53 PM EDT
Comments
Loading...
Eli Lilly Stock Guidance | NYSE:LLY | Benzinga
Eli Lilly issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/06/2025 | LLY | Eli Lilly | FY | 2025 | $22.50 | $24.00 | $22.69 | $58.00B | $61.00B | $58.91B | Get Alert |
| 01/14/2025 | LLY | Eli Lilly | FY | 2025 | — | — | — | $58.00B | $61.00B | $58.48B | Get Alert |
| 01/14/2025 | LLY | Eli Lilly | FY | 2024 | — | — | — | $45.00B | $45.00B | $45.55B | Get Alert |
| 01/14/2025 | LLY | Eli Lilly | Q4 | 2024 | — | — | — | $13.50B | $13.50B | $13.95B | Get Alert |
| 10/30/2024 | LLY | Eli Lilly | FY | 2024 | $13.02 | $13.52 | $13.47 | $45.40B | $46.00B | $46.24B | Get Alert |
| 08/08/2024 | LLY | Eli Lilly | FY | 2024 | $16.10 | $16.60 | $13.76 | $45.40B | $46.60B | $43.01B | Get Alert |
| 04/30/2024 | LLY | Eli Lilly and Co | FY | 2024 | $13.50 | $14.00 | $12.50 | $42.40B | $43.60B | $41.44B | Get Alert |
| 02/06/2024 | LLY | Eli Lilly | FY | 2024 | $12.20 | $12.70 | $12.43 | $40.40B | $41.60B | $39.38B | Get Alert |
| 11/02/2023 | LLY | Eli Lilly | FY | 2023 | $6.50 | $6.70 | $6.72 | $33.40B | $33.90B | $33.52B | Get Alert |
| 08/08/2023 | LLY | Eli Lilly | FY | 2023 | $9.70 | $9.90 | $8.71 | $33.40B | $33.90B | $31.44B | Get Alert |
| 04/27/2023 | LLY | Eli Lilly | FY | 2023 | $8.65 | $8.85 | $8.45 | $31.20B | $31.70B | $30.64B | Get Alert |
| 02/02/2023 | LLY | Eli Lilly | FY | 2023 | $8.35 | $8.55 | $8.28 | $30.30B | $30.80B | $30.55B | Get Alert |
| 01/19/2023 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $8.27 | $30.30B | $30.80B | $30.48B | Get Alert |
| 12/13/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.78 | $28.50B | $29.00B | $28.62B | Get Alert |
| 12/13/2022 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $9.15 | $30.30B | $30.80B | $30.12B | Get Alert |
| 11/01/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.99 | $28.50B | $29.00B | $28.85B | Get Alert |
| 08/04/2022 | LLY | Eli Lilly | FY | 2022 | $7.90 | $8.05 | $8.08 | $28.80B | $29.30B | $28.27B | Get Alert |
| 04/28/2022 | LLY | Eli Lilly | FY | 2022 | $8.15 | $8.30 | $8.19 | $28.80B | $29.30B | $26.80B | Get Alert |
| 02/03/2022 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.54 | $27.80B | $28.30B | $24.88B | Get Alert |
| 12/15/2021 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.30 | $27.80B | $28.30B | $24.73B | Get Alert |
| 12/15/2021 | LLY | Eli Lilly | FY | 2021 | $8.15 | $8.20 | $7.13 | $28.00B | $28.30B | $24.57B | Get Alert |
| 10/26/2021 | LLY | Eli Lilly | FY | 2021 | $7.95 | $8.05 | $6.80 | $27.20B | $27.60B | $23.52B | Get Alert |
| 08/03/2021 | LLY | Eli Lilly | FY | 2021 | $7.80 | $8.00 | $7.90 | $26.80B | $27.40B | $27.22B | Get Alert |
| 04/27/2021 | LLY | Eli Lilly | FY | 2021 | $7.80 | $8.00 | $8.23 | $26.60B | $27.60B | $27.69B | Get Alert |
| 01/29/2021 | LLY | Eli Lilly | FY | 2021 | $7.75 | $8.40 | $8.20 | $26.50B | $28.00B | $27.59B | Get Alert |
| 12/15/2020 | LLY | Eli Lilly | FY | 2021 | $7.75 | $8.40 | $8.07 | $26.50B | $28.00B | $26.47B | Get Alert |
| 12/15/2020 | LLY | Eli Lilly | FY | 2020 | $7.45 | $7.65 | $7.32 | $24.20B | $24.70B | $23.93B | Get Alert |
| 10/27/2020 | LLY | Eli Lilly | FY | 2020 | $7.20 | $7.40 | $7.28 | $23.70B | $24.20B | $23.91B | Get Alert |
| 07/30/2020 | LLY | Eli Lilly | FY | 2020 | $7.20 | $7.40 | $6.81 | $23.70B | $24.20B | $24.01B | Get Alert |
FAQ
What is the most recent guidance for Eli Lilly (LLY)?
The most recent guidance for Eli Lilly (LLY) was reported on February 6, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $22.50 to $24.00, compared to the estimated EPS of $22.69. Additionally, Eli Lilly forecasted revenue between $58.00B and $61.00B for the quarter.
Browse guidance and forecast on all stocks.